A 12-month randomized clinical trial indicated that consistent moderate-to-vigorous aerobic exercise was associated with a reduction in brain-predicted age difference (brain-PAD), a neuroimaging biomarker of brain aging, in physically inactive adults aged 26 to 58. Participants adhering to an exercise regimen showed a decrease in this brain aging marker compared to a control group, which exhibited a slight increase.
Study Overview
The eBACH (Effects of Behavioral Activity on Cardio- and Hematological Health) study, a randomized clinical trial, aimed to investigate the impact of aerobic exercise on brain health in early adulthood. Researchers focused on early to midlife as a period where lifestyle choices, including regular exercise, can influence brain health. The study utilized brain-predicted age difference (brain-PAD) as a key metric, which compares an individual's chronological age with their brain's apparent biological age. This marker is considered more sensitive than traditional brain scans for detecting subtle changes, particularly in younger adults.
Methodology
The trial involved 130 physically inactive but otherwise healthy adults, ranging in age from 26 to 58 years. Participants were randomly assigned to one of two groups:
- Intervention Group: Engaged in approximately 150 minutes of moderate-to-vigorous aerobic exercise per week, which included both supervised sessions and home workouts.
- Control Group: Received health information or usual care.
Brain age was evaluated for all participants at baseline and again after 12 months using brain-PAD, a neuroimaging biomarker derived from structural magnetic resonance imaging (MRI) data and machine learning algorithms. The study's primary endpoints did not include cognitive performance or dementia outcomes. Researchers also examined potential mediating factors, such as body composition, blood pressure, and brain-derived neurotrophic factor (BDNF) levels.
Key Findings
After 12 months, the study reported the following:
- Brain-PAD Reduction: Participants in the exercise group exhibited an average reduction of approximately 0.60 years in their brain-PAD. In contrast, the control group showed a non-significant increase of about 0.35 years. This resulted in a difference of nearly one year (0.95 years) in brain-PAD favoring the exercise group compared to controls.
- Cardiorespiratory Fitness: The exercise group also demonstrated significant improvement in cardiorespiratory fitness (CRF), as measured by maximal oxygen uptake (VO₂peak).
- Mediating Factors: The study found no significant effects of the exercise intervention on body composition, blood pressure, or circulating BDNF levels. Furthermore, mediation analysis indicated that exercise-induced improvements in CRF did not significantly influence the observed reduction in brain aging, nor did body composition, blood pressure, or BDNF.
Mechanisms and Implications
The findings suggest that a 12-month program of moderate-to-vigorous aerobic activity can enhance cardiorespiratory fitness and reduce a neuroimaging marker of brain aging in young and middle-aged adults. These results imply that higher CRF may be associated with reduced vulnerability to midlife brain aging. Dr. Kirk I. Erickson, a senior author of the study, noted that even a small difference in brain age in midlife could be relevant for long-term health outcomes. Researchers suggest that exercise may operate through other biological mechanisms not yet identified, such as subtle changes in brain structure, reduced inflammation, improved vascular health, or other molecular factors.
Limitations and Future Research
The authors noted several limitations, including that approximately 62 percent of participants completed post-intervention brain imaging. Additionally, the study population consisted predominantly of healthy individuals, which may have impacted the mediation analysis results. Further long-term studies are recommended with larger participant groups to fully understand the pathways through which exercise impacts brain age in early to midlife and to determine if these brain-PAD changes translate into sustained cognitive or clinical benefits.